{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:01:37Z","timestamp":1774778497963,"version":"3.50.1"},"reference-count":67,"publisher":"American Veterinary Medical Association (AVMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec id=\"s001\">\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>To examine the effects of imidazoline and nonimidazoline \u03b1-adrenergic agents on aggregation of feline platelets.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"s002\">\n<jats:title>SAMPLE<\/jats:title>\n<jats:p>Blood samples from 12 healthy adult cats.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"s003\">\n<jats:title>PROCEDURES<\/jats:title>\n<jats:p>In 7 experiments, the effects of 23 imidazoline and nonimidazoline \u03b1-adrenoceptor agonists or antagonists on aggregation and antiaggregation of feline platelets were determined via a turbidimetric method. Collagen and ADP were used to initiate aggregation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"s004\">\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Platelet aggregation was not induced by \u03b1-adrenoceptor agonists alone. Adrenaline and noradrenaline induced a dose-dependent potentiation of ADP- or collagen-induced aggregation. Oxymetazoline and xylometazoline also induced a small potentiation of ADP-stimulated aggregation, but other \u03b1-adrenoceptor agonists did not induce potentiation. The \u03b1<jats:sub>2<\/jats:sub>-adrenoceptor antagonists and certain imidazoline \u03b1-adrenergic agents including phentolamine, yohimbine, atipamezole, clonidine, medetomidine, and dexmedetomidine inhibited adrenaline-potentiated aggregation induced by ADP or collagen in a dose-dependent manner. The imidazoline compound antazoline inhibited adrenaline-potentiated aggregation in a dose-dependent manner. Conversely, \u03b1<jats:sub>1<\/jats:sub>-adrenoceptor antagonists and nonimidazoline \u03b1-adrenergic agents including xylazine and prazosin were ineffective or less effective for inhibiting adrenaline-potentiated aggregation. Moxonidine also was ineffective for inhibiting adrenaline-potentiated aggregation induced by collagen. Medetomidine and xylazine did not reverse the inhibitory effect of atipamezole and yohimbine on adrenaline-potentiated aggregation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"s005\">\n<jats:title>CONCLUSIONS AND CLINICAL RELEVANCE<\/jats:title>\n<jats:p>Adrenaline-potentiated aggregation of feline platelets may be mediated by \u03b1<jats:sub>2<\/jats:sub>-adrenoceptors, whereas imidazoline agents may inhibit in vitro platelet aggregation via imidazoline receptors. Imidazoline \u03b1-adrenergic agents may have clinical use for conditions in which there is platelet reactivity to adrenaline. Xylazine, medetomidine, and dexmedetomidine may be used clinically in cats with minimal concerns for adverse effects on platelet function.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/ajvr.81.2.159","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T15:03:11Z","timestamp":1580137391000},"page":"159-171","source":"Crossref","is-referenced-by-count":5,"title":["Effects of imidazoline and nonimidazoline \u03b1-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets"],"prefix":"10.2460","volume":"81","author":[{"given":"Takuya","family":"Matsukawa","sequence":"first","affiliation":[{"name":"1United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi 753\u20138515, Japan."},{"name":"2Joint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680\u20138553, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Hikasa","sequence":"additional","affiliation":[{"name":"2Joint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680\u20138553, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Thromb Diath Haemorrh","first-page":"99","article-title":"Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study","volume":"17","author":"Sinakos","year":"1967"},{"key":"ref2","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1476-5381.1984.tb10748.x","article-title":"Mammalian platelet adrenoceptors","volume":"81","author":"Kerry","year":"1984"},{"key":"ref3","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/sj.bjp.0703928","article-title":"Inhibition of aggregation of rabbit and human platelets induced by adrenaline and 5-hydroxytryptamine by KB-R7943, a Na(+)\/Ca(2+) exchange inhibitor","volume":"132","author":"Takano","year":"2001"},{"key":"ref4","series-title":"Nature","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/277659a0","article-title":"Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation","volume":"277","author":"Grant","year":"1979"},{"key":"ref5","series-title":"J Pharmacol Exp Ther","first-page":"366","article-title":"The effects of alpha adrenergic agents on human platelet aggregation","volume":"208","author":"Hsu","year":"1979"},{"key":"ref6","series-title":"Naunyn Schmiedebergs Arch Pharmacol","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00498981","article-title":"Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets","volume":"306","author":"Lasch","year":"1979"},{"key":"ref7","series-title":"J Pharm Pharmacol","first-page":"213","article-title":"The effects of imidazoline agents on the aggregation of human platelets","volume":"56","author":"Pinthong","year":"2004"},{"key":"ref8","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejphar.2013.10.003","article-title":"Identification and characterization of platelet \u03b12-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses","volume":"720","author":"Hikasa","year":"2013"},{"key":"ref9","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/S0006-291X(80)80044-1","article-title":"Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine","volume":"97","author":"Motulsky","year":"1980"},{"key":"ref10","series-title":"Mol Pharmacol","first-page":"179","article-title":"Characterization of alpha-adrenergic receptors in human platelets using [3H] clonidine","volume":"19","author":"Shattil","year":"1981"},{"key":"ref11","series-title":"Biochem Pharmacol","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/0006-2952(82)90705-5","article-title":"[3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H] yohimbine, and [3H]rauwolscine","volume":"31","author":"Motulsky","year":"1982"},{"key":"ref12","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1055\/s-0038-1657749","article-title":"Studies of \u03b12-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine-correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation","volume":"54","author":"Lanza","year":"1985"},{"key":"ref13","series-title":"Atherosclerosis","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0021-9150(85)90070-X","article-title":"Effect on human platelets of catecholamines at levels achieved in the circulation","volume":"58","author":"Ardlie","year":"1985"},{"key":"ref14","series-title":"Arterioscler Thromb","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/01.ATV.14.1.77","article-title":"Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression","volume":"14","author":"Hjemdahl","year":"1994"},{"key":"ref15","series-title":"Pharmacology","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000028279","article-title":"Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation","volume":"58","author":"Hikasa","year":"1999"},{"key":"ref16","series-title":"Thromb Diath Haemorrh","first-page":"601","article-title":"Aggregation of cat platelets in vitro","volume":"23","author":"Tschopp","year":"1970"},{"key":"ref17","series-title":"Tierarztl Prax","first-page":"413","article-title":"Thrombocyte aggregation in the cat","volume":"19","author":"Hart","year":"1991"},{"key":"ref18","series-title":"Pharmacology","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000346269","article-title":"Effects of imidazoline and non-imidazoline \u03b1-adrenergic agents on rabbit platelet aggregation","volume":"91","author":"Yokota","year":"2013"},{"key":"ref19","series-title":"Comp Biochem Physiol C","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0742-8413(89)90204-1","article-title":"Characterization of the normal bovine platelet aggregation response","volume":"92","author":"Bondy","year":"1989"},{"key":"ref20","series-title":"J Surg Res","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1006\/jsre.1998.5543","article-title":"Whole blood platelet aggregation in humans and animals: a comparative study","volume":"82","author":"Soloviev","year":"1999"},{"key":"ref21","series-title":"J Vet Med Sci","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1292\/jvms.58.647","article-title":"Inhibition of collagen-induced platelet aggregation in Japanese black cattle with inherited platelet disorder, Chediak-Higashi syndrome","volume":"58","author":"Suzuki","year":"1996"},{"key":"ref22","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2460\/ajvr.74.3.395","article-title":"Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets","volume":"74","author":"Yokota","year":"2013"},{"key":"ref23","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1161\/01.CIR.86.6.1859","article-title":"Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation","volume":"86","author":"Goto","year":"1992"},{"key":"ref24","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-0038-1650239","article-title":"Epinephrine augments platelet recruitment to immobilized collagen in flowing blood\u2014evidence for a von Willebrand factor-mediated mechanism","volume":"75","author":"Mustonen","year":"1996"},{"key":"ref25","series-title":"J Feline Med Surg","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jfms.2009.10.010","article-title":"Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma","volume":"12","author":"Wimpole","year":"2010"},{"key":"ref26","series-title":"J Physiol","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1113\/jphysiol.1971.sp009368","article-title":"Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs","volume":"213","author":"Hall","year":"1971"},{"key":"ref27","series-title":"J Pharm Pharmacol","first-page":"576","article-title":"Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia","volume":"33","author":"Feuerstein","year":"1981"},{"key":"ref28","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1939-1676.2002.tb02343.x","article-title":"Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine","volume":"16","author":"Rand","year":"2002"},{"key":"ref29","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2460\/javma.242.12.1715","article-title":"Evaluation of risk factors for outcome associated with adrenal gland tumors with or without invasion of the caudal vena cava and treated via adrenalectomy in dogs: 86 cases (1993\u20132009)","volume":"242","author":"Barrera","year":"2013"},{"key":"ref30","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5326\/15473317-33-1-33","article-title":"Apocrine gland adenocarcinoma and pheochromocytoma in a cat","volume":"33","author":"Chun","year":"1997"},{"key":"ref31","series-title":"Intern Emerg Med","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11739-007-0026-X","article-title":"The coagulation system in endocrine disorders: a narrative review","volume":"2","author":"Squizzato","year":"2007"},{"key":"ref32","series-title":"Vet Immunol Immunopathol","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetimm.2009.06.002","article-title":"Systemic response to low-dose endotoxin infusion in cats","volume":"132","author":"DeClue","year":"2009"},{"key":"ref33","series-title":"J Lab Clin Med","first-page":"779","article-title":"Clonidine and para-aminoclonidine, partial agonists for the alpha2-adrenergic receptor on intact human blood platelets","volume":"102","author":"Stump","year":"1983"},{"key":"ref34","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.1073\/pnas.83.23.9197","article-title":"Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb\/IIIa and dual role of epinephrine","volume":"83","author":"Banga","year":"1986"},{"key":"ref35","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.1984.tb10782.x","article-title":"Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets","volume":"82","author":"Clare","year":"1984"},{"key":"ref36","series-title":"Anesthesiology","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/ALN.0b013e318164ca81","article-title":"Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors","volume":"108","author":"Dahmani","year":"2008"},{"key":"ref37","series-title":"Biochem Pharmacol","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/0006-2952(86)90117-6","article-title":"Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity","volume":"35","author":"Ferry","year":"1986"},{"key":"ref38","series-title":"Eur J Biochem","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1432-1033.1984.tb08462.x","article-title":"Isolation and partial purification of a clonidine-displacing endogenous brain substance","volume":"144","author":"Atlas","year":"1984"},{"key":"ref39","series-title":"Life Sci","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0024-3205(86)90248-1","article-title":"An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla","volume":"38","author":"Meeley","year":"1986"},{"key":"ref40","series-title":"Mol Pharmacol","first-page":"65","article-title":"Nonadrenergic [3H] idazoxan binding sites are physically distinct from alpha 2-adrenergic receptors","volume":"37","author":"Michel","year":"1990"},{"key":"ref41","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-2999(90)94127-J","article-title":"Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?","volume":"190","author":"Zonnenchein","year":"1990"},{"key":"ref42","series-title":"J Pharmacol Exp Ther","first-page":"1493","article-title":"Nonadrenergic imidazoline binding sites on human platelets","volume":"267","author":"Piletz","year":"1993"},{"key":"ref43","series-title":"J Pharmacol Exp Ther","first-page":"694","article-title":"Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes","volume":"279","author":"Piletz","year":"1996"},{"key":"ref44","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1055\/s-0038-1660133","article-title":"Effects of imidazoline drugs on human blood platelets aggregation","volume":"54","author":"Petrusewicz","year":"1985"},{"key":"ref45","series-title":"Pharmacology","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000138223","article-title":"Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs","volume":"33","author":"Petrusewicz","year":"1986"},{"key":"ref46","series-title":"Gen Pharmacol","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0306-3623(91)90213-P","article-title":"Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation","volume":"22","author":"Petrusewicz","year":"1991"},{"key":"ref47","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1096\/fasebj.6.3.1346768","article-title":"Subtypes of alpha 1- and alpha 2-adrenergic receptors","volume":"6","author":"Bylund","year":"1992"},{"key":"ref48","series-title":"J Pharmacol Exp Ther","first-page":"600","article-title":"Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype","volume":"245","author":"Bylund","year":"1988"},{"key":"ref49","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1016\/S0021-9258(19)84432-0","article-title":"Evidence that Na+\/ H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets","volume":"261","author":"Sweatt","year":"1986"},{"key":"ref50","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"46035","DOI":"10.1074\/jbc.M208519200","article-title":"Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors","volume":"277","author":"Yang","year":"2002"},{"key":"ref51","series-title":"Thromb Res","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0049-3848(01)00388-7","article-title":"Epinephrine-via activation of p38-MAPK\u2013abolishes the effect of aspirin on platelet deposition to collagen","volume":"104","author":"Mustonen","year":"2001"},{"key":"ref52","series-title":"Blood Coagul Fibrinolysis","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00001721-199603000-00035","article-title":"cAMP is not an important messenger for ADP-induced platelet aggregation","volume":"7","author":"Savi","year":"1996"},{"key":"ref53","series-title":"Platelets","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/09537109976086","article-title":"cAMP is an important messenger for ADP-induced platelet aggregation","volume":"10","author":"Weber","year":"1999"},{"key":"ref54","series-title":"Trends Pharmacol Sci","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0165-6147(98)01244-9","article-title":"\u2018Seeing through a glass darkly\u2019: casting light on imidazoline \u2018I\u2019 sites","volume":"19","author":"Eglen","year":"1998"},{"key":"ref55","series-title":"Naunyn Schmiedebergs Arch Pharmacol","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/PL00005243","article-title":"Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors","volume":"358","author":"A","year":"1998"},{"key":"ref56","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.bjp.0701296","article-title":"Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype","volume":"121","author":"MacLennan","year":"1997"},{"key":"ref57","series-title":"Int J Pharmacol","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3923\/ijp.2015.625.631","article-title":"Effects of imidazoline and nonimidazoline \u03b12-adrenergic agents on intracellular cyclic AMP and thromboxane B2 concentrations in canine and leporine platelets","volume":"11","author":"S-I","year":"2015"},{"key":"ref58","series-title":"J Pharmacol Exp Ther","first-page":"682","article-title":"Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination","volume":"263","author":"Winter","year":"1992"},{"key":"ref59","series-title":"Arzneimittelforschung","first-page":"1","article-title":"Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors","volume":"44","author":"Kawai","year":"1994"},{"key":"ref60","series-title":"Mol Pharmacol","first-page":"1","article-title":"Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line","volume":"34","author":"Murphy","year":"1988"},{"key":"ref61","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0014-2999(91)90432-P","article-title":"Interaction of the alpha-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors","volume":"196","author":"Schoeffter","year":"1991"},{"key":"ref62","series-title":"Neurochem Res","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s11064-007-9582-8","article-title":"Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets","volume":"33","author":"Trincavelli","year":"2008"},{"key":"ref63","series-title":"Thromb Res","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0049-3848(84)90166-X","article-title":"The involvement of 5-HT2-receptor sites in the activation of cat platelets","volume":"33","author":"De Clerck","year":"1984"},{"key":"ref64","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","article-title":"The pharmacokinetics of xylazine hydrochloride: an interspecific study","volume":"4","author":"R","year":"1981"},{"key":"ref65","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2885.2000.00245.x","article-title":"Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs","volume":"23","author":"Kuusela","year":"2000"},{"key":"ref66","series-title":"Vet Anaesth Analg","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.vaa.2017.02.008","article-title":"Pharmacokinetics of dexmedetomidine, MK-467 and their combination following intramuscular administration in male cats","volume":"44","author":"Pypendop","year":"2017"},{"key":"ref67","series-title":"Surg Gynecol Obstet","first-page":"73","article-title":"The role of intravascular coagulation in feline endotoxin shock","volume":"134","author":"Lucas","year":"1972"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/81\/2\/ajvr.81.2.159.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/81\/2\/ajvr.81.2.159.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/81\/2\/ajvr.81.2.159.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T20:43:51Z","timestamp":1696538631000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/81\/2\/ajvr.81.2.159.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":67,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.81.2.159","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}